✓ Editorial reviews of U.S. telehealth programs · Prices and dates shown on each page · Educational only — not medical advice
Clinical Reference

Drug Interactions

Released: Last reviewed:

Key interactions: oral medications (delayed gastric emptying), insulin and sulfonylureas (hypoglycemia risk), oral contraceptives (PK considerations).

Clinical reference
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 20, 2026 · This page is informational and does not constitute medical advice.

Overview

Key interactions: oral medications (delayed gastric emptying), insulin and sulfonylureas (hypoglycemia risk), oral contraceptives (PK considerations).

Related clinical pages

Key facts, checked November 20, 2026

The Wegovy label lists two interaction areas. First, semaglutide lowers blood sugar, so the risk of hypoglycemia rises with insulin or insulin secretagogues such as sulfonylureas, and the label suggests considering lower doses of those drugs when starting. Second, it delays gastric emptying, which can affect the absorption of oral medicines taken at the same time. Tell the prescriber about every medicine and supplement you take, and ask a pharmacist about timing. FDA’s November 9, 2026 safety communication adds a new class-wide eye warning to approved GLP-1 labels.